Hormonal regulation of ENaCs: insulin and aldosterone.
Although a variety of hormones and other agents modulate renal Na+ transport acting by way of the epithelial Na+ channel (ENaC), the mode(s), pathways, and their interrelationships in regulation of the channel remain largely unknown. It is likely that several hormones may be present concurrently in vivo, and it is, therefore, important to understand potential interactions among the various regulatory factors as they interact with the Na+ transport pathway to effect modulation of Na+ reabsorption in distal tubules and other native tissues. This study represents specifically a determination of the interaction between two hormones, namely, aldosterone and insulin, which stimulate Na+ transport by entirely different mechanisms. We have used a noninvasive pulse protocol of blocker-induced noise analysis to determine changes in single-channel current (iNa), channel open probability (Po), and functional channel density (NT) of amiloride-sensitive ENaCs at various time points following treatment with insulin for 3 h of unstimulated control and aldosterone-pretreated A6 epithelia. Independent of threefold differences of baseline values of transport caused by aldosterone, 20 nM insulin increased by threefold and within 10-30 min the density of the pool of apical membrane ENaCs (NT) involved in transport. The very early (10 min) increases of channel density were accompanied by relatively small decreases of iNa (10-20%) and decreases of p.o. (28%) in the aldosterone-pretreated tissues but not the control unstimulated tissues. The early changes of iNa, p.o., and NT were transient, returning very slowly over 3 h toward their respective control values at the time of addition of insulin. We conclude that aldosterone and insulin act independently to stimulate apical Na+ entry into the cells of A6 epithelia by increase of channel density.
Blazer-Yost
B L
BL
Biology Department, Indiana University-Purdue University at Indianapolis 46202, USA.
Liu
X
X
Helman
S I
SI
D000450:Aldosterone / Q000494:pharmacology*; D000584:Amiloride / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D002460:Cell Line; D004347:Drug Interactions; D004553:Electric Conductivity; D053503:Epithelial Sodium Channels; D007328:Insulin / Q000494:pharmacology*; D007668:Kidney / Q000166:cytology / Q000378:metabolism*; D015222:Sodium Channels / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology; D014982:Xenopus laevis
D053503:Epithelial Sodium Channels; D007328:Insulin; D015222:Sodium Channels; C058206:6-chloro-3,5-diaminopyrazine-3-carboxamide; D000450:Aldosterone; D000584:Amiloride